logo
Select company
Select metric
$ -1.67EBITDA per Share
VS
Market
13
Sector
36
Industry
48
History
-
$ 26.76Close
$ 21.77 - $ 66.83 52-Week Range
Ticker Information

Ticker

JANX

Company Name

JANUX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

JANUX THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

JANX - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -103.56M$ -1.67161.9M
3/31/2025$ -75.69M$ -1.23161.79M
12/31/2024$ -66.93M$ -1.25153.75M
9/30/2024$ -58.46M$ -1.07154.63M
6/30/2024$ -41.98M$ -0.77154.45M
3/31/2024$ -53.56M$ -1.09149.05M
12/31/2023$ -56.34M$ -1.28144.02M
9/30/2023$ -60.77M$ -1.33145.71M
6/30/2023$ -66.15M$ -1.58141.84M
3/31/2023$ -65.89M$ -1.58141.76M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • JANUX THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
  • Over the past 5 years, JANUX THERAPEUTICS INC's average EBITDAPS has been $ -1.3.
  • The median EBITDAPS for JANUX THERAPEUTICS INC during this period was $ -1.31
  • JANUX THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -0.77.
  • The lowest EBITDAPS recorded by JANUX THERAPEUTICS INC in the same timeframe $ -1.67

JANUX THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
VRDN : VIRIDIAN THERAPEUTICS INC $ -4.17CGON : CG ONCOLOGY INC $ -1.68PROK : PROKIDNEY CORP $ -0.5ABEO : ABEONA THERAPEUTICS INC $ 1.52AVTX : AVALO THERAPEUTICS INC $ -4.42MREO : MEREO BIOPHARMA GROUP PLC $ -0.31COYA : COYA THERAPEUTICS INC $ -1.26ETNB : 89BIO INC $ -2.8EWTX : EDGEWISE THERAPEUTICS INC $ -1.41DYN : DYNE THERAPEUTICS INC $ -3.61

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for JANUX THERAPEUTICS INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 1.11M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]

JANX - EBITDA per Share, Last 5 years

$ -1.67

Minimum

Jun 30, 2025

$ -0.77

Maximum

Jun 30, 2024

$ -1.3

Average

$ -1.31

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26